Physician profile
David Spragg
NPI 1316984776
$22,269.34
in general payments reported to CMS, 2019-2025
13 companies · $7,667 in 2025
The $7,667 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.69 · 2020: $2,450 · 2021: $50.63 · 2022: $8,034 · 2023: $1,650 · 2024: $2,393 · 2025: $7,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,750 · Food and Beverage: $2,201 · Travel and Lodging: $1,559 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,750.00 |
| Food and Beverage | $2,201.23 |
| Travel and Lodging | $1,558.53 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $17,432.61 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Pfizer INC. | $2,473.09 | 2020-2025 | |
| Altathera Pharmaceuticals LLC | $1,322.32 | 2023 | Sotalol Hydrochloride |
| Abbott Laboratories | $672.61 | 2022-2025 | Aveir, Ensite Precision, Perclose Prostyle |
| Boston Scientific Corporation | $167.72 | 2023-2025 | Rhythmia Mapping System, Farapulse, Watchman Flx |
| Stryker Corporation | $53.44 | 2023 | N/A |
| Ethicon US, LLC | $44.16 | 2023 | Ethicon |
| Terumo Medical Corporation | $31.10 | 2024-2025 | Metacross Otw, Glidewire, Angio-Seal |
| Atricure, INC. | $25.65 | 2022 | |
| Medtronic Vascular, INC. | $24.69 | 2019 | |
| Medtronic, INC. | $11.97 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.98 | 2025 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.